ID   Hs 228.T
AC   CVCL_0697
SY   Hs228
DR   CLO; CLO_0003897
DR   ATCC; CRL-7193
DR   BioSample; SAMN03471529
DR   cancercelllines; CVCL_0697
DR   GEO; GSM136245
DR   GEO; GSM827357
DR   Progenetix; CVCL_0697
DR   Wikidata; Q54895523
RX   PubMed=20215515;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-7193
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 12,15
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 7,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//